Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 6Endometrial Neoplasms 6Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Prostatic Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Melanoma 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent Uterine Sarcoma 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1

Interventions

Trastuzumab 2Magnetic Resonance Spectroscopy 2tipifarnib 1temsirolimus 1sargramostim 1cabozantinib 1aldesleukin 1Vinorelbine 1Specimen Handling 1Sirolimus 1Nivolumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Fluorodeoxyglucose F18 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Medullary × Sirolimus × Gynecologic × Clear all
NCT01155258 2016-06-13

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

University of Southern California

Phase 1 Completed
19 enrolled
BreastCNSDermatologicEndocrineGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Prostatic Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡